Tip Details

10/02/2011 at 01:31PM
Med Biogene, Inc.
Med BioGene Inc.
MBI.TSV
Initial > Target price

$0.045 > $0.21
Price when coverage ended

$0.08  77.78%
Best up to date ROI

$0.14  211.11%
7 votes
Coverage ended

Initial price $0.045 Start coverage 10/02/2011
Target price $0.21 End coverage 07/04/2011
Highest price $0.14 Experience 76.25 pts
Description The company?s products include LungExpress Dx, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patient?s tumor to provide information to assist in tailoring treatment for that specific patient; and LymphExpress Dx, a gene expression-based microarray diagnostic test for common subtypes of lymphoma.

Report abuse !
Share this tip |

Industry: | Symbol: | Exchange:

Last months Activity

1 comment
2011 March 1 at 9:55AM
From tapnet | Rank: 0 | Avg ROI + 54.7 %

Its ready to pop today!! Check out this headline about LungExpress Dx http://finance.yahoo.com/news/Precision-Therapeutics-and-ccn-2506522695.html?x=0&.v=1 Its ready to pop today!! Check out this headline about LungExpress Dx http://finance.yahoo.com/news/Precision-Therapeutics-and-ccn-2506522695.html?x=0&.v=1

Comment on this tip
Only Stocktipr members can share comments on tips, register now



About Med Biogene, Inc.

tapnet initiated a coverage Med Biogene, Inc. on on 10/02/2011 at 01:31PM. Med BioGene Inc. is listed in the sector. The stock was priced $0.045 when tapnet posted the tip. After analyzing the company activities and performance, tapnet believes Med BioGene Inc. has the potential to reach $0.21. As of 10/02/2011, the highest price Med BioGene Inc. has traded at is $0.14.



Back to Tips listing

StockTipr is in constant evolution. Contribute by sending us your suggestions and comments

Send us your commentsSend us your comments